The aim of the current study was to design oral controlled release mucoadhesive compressed hydrophilic matrices of atenolol and to optimize the drug release profile and bioadhesion using response surface methodology. Tablets were prepared by direct compression and evaluated for bioadhesive strength and in vitro dissolution parameters. A central composite design for 2 factors at 3 levels each was employed to systematically optimize drug release profile and bioadhesive strength. Carbopol 934P and sodium carboxymethylcellulose were taken as the independent variables. Response surface plots and contour plots were drawn, and optimum formulations were selected by feasibility and grid searches. Compressed matrices exhibited non-Fickian drug release kinetics approaching zero-order, as the value of release rate exponent (n) varied between 0.6672 and 0.8646, resulting in regulated and complete release until 24 hours. Both the polymers had significant effect on the bioadhesive strength of the tablets, measured as force of detachment against porcine gastric mucosa (P < .001). Polynomial mathematical models, generated for various response variables using multiple linear regression analysis, were found to be statistically significant (P < .01). Validation of optimization study, performed using 8 confirmatory runs, indicated very high degree of prognostic ability of response surface methodology, with mean percentage error (± SD) as −0.0072 ± 1.087. Besides unraveling the effect of the 2 factors on the various response variables, the study helped in finding the optimum formulation with excellent bioadhesive strength and controlled release.
INTRODUCTION
Oral controlled release (CR) systems continue to be the most popular ones among all the drug delivery systems. 1 Mucoadhesive delivery systems offer several advantages over other oral CR systems by virtue of prolongation of residence time of drug in gastrointestinal (GI) tract, and targeting and localization of the dosage form at a specific site. [1] [2] [3] [4] Also, these mucoadhesive systems are known to provide intimate contact between dosage form and the absorptive mucosa, resulting thereby in high drug flux through the absorbing tissue. 1, 2, 5 Atenolol, a β-blocker, is prescribed widely in diverse cardiovascular diseases, eg, hypertension, angina pectoris, arrhythmias, and myocardial infarction. 6 The drug is also frequently indicated in the prophylactic treatment of migraine. Administration of conventional tablets of atenolol has been reported to exhibit fluctuations in the plasma drug levels, resulting either in manifestation of side effects or reduction in drug concentration at the receptor site. 7, 8 Accordingly, studies have been reported on regulation of drug release by formulating its diverse CR systems such as hydrophilic matrices, 9-11 osmotic pumps, 7, 8, 12, 13 and transdermal drug delivery systems. 14 Response surface methodology (RSM) is a widely practiced approach in the development and optimization of drug delivery devices. [15] [16] [17] [18] [19] [20] Based on the principal of design of experiments (DoE), the methodology encompasses the use of various types of experimental designs, generation of polynomial equations, and mapping of the response over the experimental domain to determine the optimum formulation(s). 17, 21 The technique requires minimum experimentation and time, thus proving to be far more effective and cost-effective than the conventional methods of formulating dosage forms.
The current study aims at developing and optimizing an oral mucoadhesive drug delivery system of atenolol using RSM, as it may prove to be more productive than the conventional CR systems by virtue of prolongation of drug residence time in GI tract. Further, mucoadhesive tablets of the drug would involve relatively more economical and less complicated technology vis-à-vis many other drug delivery devices such as osmotic and transdermal delivery systems. Computer-aided optimization technique, using a central composite design (CCD), was employed to investigate the effect of 2 independent variables (factors) (ie, the amounts of 2 swellable polymers) on drug release parameters and bioadhesive strength.
MATERIALS AND METHODS

Materials
Atenolol was provided ex gratia by IPCA Laboratories Ltd (Mumbai, India) and Carbopol 934P (CP) was a gift from Noveon Pharmaceuticals (Cleveland, OH). High-viscosity grade sodium carboxymethylcellulose (Na CMC) was obtained from Loba-Chemie Indoaustranat Co (Mumbai, India). Porcine gastric mucosa, for determining bioadhesive strength, was obtained from a local slaughter house in Chandigarh, India. All other chemicals employed were of analytical grade. Table 1 enlists the composition of different mucoadhesive formulations prepared using varying amounts of the polymers (ie, CP and Na CMC) and dicalcium phosphate as the diluent, along with the fixed quantity of magnesium stearate as the lubricant. Drug and the excipients were homogeneously blended and subsequently compressed into flat-faced tablets (410 mg, 12.9-mm diameter) using single-punch tablet compression machine (Cadmach, Ahmedabad, India).
Methods
Preparation of Mucoadhesive Compressed Matrices
Experimental Design
A CCD with α = 1 was employed as per the standard protocol. 16, 19 The amounts of CP (X 1 ) and Na CMC (X 2 ) were selected as the factors, studied at 3 levels each. The central point (0,0) was studied in quintuplicate. All other formulation and processing variables were kept invariant throughout the study. Table 2 summarizes an account of the 13 experimental runs studied, their factor combinations, and the translation of the coded levels to the experimental units employed during the study. Time taken to release 50% of the drug (t 50% ), release until 18 hours (rel 18h ), diffusional release exponent (n), and bioadhesive strength ( f ) were taken as the response variables.
Tablet Assay and Physical Evaluation
The tablets were assayed for drug content using methanol as the extracting solvent, and the samples were analyzed spectrophotometrically (Shimadzu 1601, Kyoto, Japan) at 275 nm. Tablets were also evaluated for hardness (n = 6), friability (n = 6), weight variation (n = 10), and thickness (n = 10).
In Vitro Drug Release Studies
Dissolution studies were performed for all the formulation combinations, in triplicate, employing United States Pharmacopeia(USP)-28 paddle method (Pharmatest PTW II, Pharmatest Apparatus, Hainburg, Germany) and phosphate buffer solution pH 6.8 (PBS) as the dissolution medium at 50 rpm and 37°C ± 0.5°C. A 5-mL aliquot of the sample was withdrawn periodically at suitable time intervals and the volume replaced with an equivalent amount of the plain dissolution medium. The samples were analyzed spectrophotometrically at 276 nm. Drug release data were analyzed using ZOREL software 22 after correcting the values for the drug loss occurred during sampling. Based primarily on the algorithms proposed by Peppas and Sahlin, 23, 24 the software reports the values of the release exponent (n) indicating the kinetics of drug release, the kinetic constant (k), magnitudinal contributions of the Fickian diffusion (k 1 ) and polymer relaxation (k 2 ), respectively. As the current study involved unequal time intervals in the entire 24-hour dissolution span, the weighted mean of drug release rate was computed with time intervals as the weights. Drug release profiles were drawn using MS-Excel software and the values of t 50% were interpolated by Stineman interpolation using GRAPH software (Version 2.0, MicroMath Inc, St Louis, MO).
Ex Vivo Bioadhesion Studies
Bioadhesion studies were conducted, using a modification of the assembly described earlier, 25 with porcine gastric mucosa as the model membrane. The mucosal membrane was excised by removing the underlying connective and adipose tissue, and equilibrated at 37°C ± 1°C for 30 minutes in PBS before the bioadhesion evaluation study. The tablet was lowered onto the mucosa under a constant weight of 5 g for a total contact period of 1 minute. Bioadhesive strength ( f ) was assessed in terms of the weight in grams required to detach the tablet from the membrane. To investigate the effect of the individual polymer on bioadhesive strength, a 2-way analysis of variance (ANOVA)-based factorial analysis was performed as per the standard algorithms. 26 
Optimization Data Analysis and Validation of Optimization Model
Various RSM computations for the current optimization study were performed employing Design Expert software (Version 6.0.10, Stat-Ease Inc, Minneapolis, MN). Polynomial models including interaction and quadratic terms were generated for all the response variables using multiple linear regression analysis (MLRA) approach. The general form of the MLRA model is represented as Equation 1.
where, β 0 is the intercept representing the arithmetic average of all quantitative outcomes of 13 runs; β 1 to β 7 are the coefficients computed from the observed experimental values of Y; and X 1 and X 2 are the coded levels of the independent variable(s). The terms X 1 X 2 and X i 2 (i = 1 to 2) represent the interaction and quadratic terms, respectively. Statistical validity of the polynomials was established on the basis of ANOVA provision in the Design Expert software. Subsequently, the feasibility and grid searches were performed to locate the composition of optimum formulations. 21, 25 Also, the 3-D response surface graphs and 2-D contour plots were constructed in MS-Excel environment using the output files generated by the Design Expert software.
Eight optimum checkpoints were selected by intensive grid search, performed over the entire experimental domain, to validate the chosen experimental design and polynomial equations. The formulations corresponding to these checkpoints were prepared and evaluated for various response properties. Subsequently, the resultant experimental data of response properties were quantitatively compared with that of the predicted values. Also, linear regression plots between observed and predicted values of the response properties were drawn using MS-Excel, forcing the line through origin.
RESULTS AND DISCUSSION
Drug Content and Physical Evaluation
The assayed content of drug in various formulations varied between 98.9% and 100.9% (mean 99.9%). Tablet ), and friability ranged between 0.29% and 0.53% (mean 0.34%). Thus, all the physical parameters of the compressed matrices were practically within control. Table 3 lists various dissolution parameters computed for all the CR bioadhesive formulations. In the current study, the values of release rate exponent (n), calculated as per the algorithm proposed by Peppas and Sahlin, 23 ranged between 0.6672 and 0.8646. Using an aspect ratio of 5.4, the critical values of n for declaring Fickian diffusion and zero-order release were found to be 0.4500 and 0.9000, respectively. In general, the release pattern was found to be non-Fickian tending to approach zero-order, especially when intermediate levels of Na CMC were coupled with intermediate to high levels of CP. The values of kinetic constant (k), being a direct function of matrix solubility, were found to decline with increase in the amount of either polymer, in accordance with the characteristic nature of the parameter. 27, 28 Much higher values of k 1 vis-à-vis k 2 clearly indicate that the drug release was governed predominantly by Fickian diffusion, with varying contribution of polymer relaxation (case 2 transport) mechanism as well. The contribution of case 2 relaxation (due to polymer swelling and erosion) tended to show an increasing trend with increase in the content of any of the polymers, except when high levels of Na CMC were used in conjunction with intermediate to high levels of CP.
In Vitro Drug Release Studies
Total amount of atenolol released from all the formulations until 24 hours ranged between 93.86% and 100.01% indicating almost complete drug release from all the formulations. As the mean values of overall rate of drug release
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until 24 hours for all the formulations were not found to be discriminating, overall rate of drug release was computed until 18 hours. Rate of drug release (until 18 hours) tended to decrease with increase in the content of either CP or Na CMC. This is in agreement with literature findings 29, 30 that the viscosity of the gel layer around the tablet increases with increase in the hydrogel concentration, thus limiting the release of active ingredient. As the carboxyl groups of CP dissociate highly at pH above their pK a (ie, 6.0 ± 0.5), electrostatic repulsions between the negatively charged carboxyl groups cause uncoiling and expansion of molecules, resulting in polymer swelling and consequent gel formation. 30, 31 The gel, thus formed, consists of closely packed swollen particles. With further increase in polymer amount, thicker gel forms inhibiting water penetration more strongly, resulting in significant reduction in the values of rel 18h indicating slower drug release. At high levels of both the polymers, a significant fraction of the drug (~28%) remained unreleased until 18 hours, which can eventually lead to significant reduction in the extent of bioavailability. Hence, in the subsequent RSM optimization studies, due consideration was taken to control the drug release profile without significant loss of unreleased drug in the formulation. Nevertheless, the loss in drug bioavailability is expected to be less in the light of the in vivo situation, where the bioadhesive dosage form is likely to be in intimate contact with the biological tissue for longer periods of time.
The values of t 50% enhanced markedly from 3.71 hours, observed at low levels of both the polymers, to as high as 9.91 hours, observed at high levels of both the polymers. This finding indicated considerable release-retarding potential of the polymers for atenolol. Figure 1 exhibits the dissolution profiles obtained for various formulations, prepared as per CCD. The formulations with lower levels of polymers exhibited higher initial burst in drug release (Figure 1 inset) . This result could be attributed to the dissolution of drug present initially at the surface of the matrices and the availability of higher amount of unreleased drug present in the dosage form. This could also be because the dosage forms, in the early dissolution period, exhibit primarily first-order Fickian diffusion mechanism. The higher amount of drug released due to Fickian diffusion (ie, due to k 1 ) vis-à-vis that released due to polymer relaxation (ie, due to k 2 ) in early time periods also corroborates the same. Cumulative proportion of drug released due to case 2 relaxational transport constant (k 2 ) increased for all the formulations with increasing dissolution time period, indicating that the release was significantly influenced by polymer relaxation in the later stages (data not shown). However, the formulations showed little burst effect at higher polymer levels, ratifying better sustenance of drug release. Overall, all the formulations showed quite regulated release from 4 hours onwards.
Ex Vivo Bioadhesive Strength Determination Figure 2 shows the bar chart depicting significant variation in the values of bioadhesive strength, obtained using different ratios of polymers. The figure depicts an increasing trend in bioadhesive strength, as observed with porcine mucosa, with an increase in the amount of either polymer. Maximum bioadhesive strength, therefore, was seen at the 
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highest levels of the 2 polymers. The hydrogels are known to swell readily, when they come in contact with hydrated mucous membrane. 2, 31 Water sorption reduces the glass transition temperature below ambient conditions, and hydrogels become progressively rubbery due to uncoiling of polymer chains and subsequent increased mobility of the polymer chains. This glass-rubbery transition provides hydrogel plasticization resulting in a large adhesive surface for maximum contact with mucin and flexibility to the polymer chains for interpenetration with mucin. 31, 32 Increasing the polymer amount may provide more adhesive sites and polymer chains for interpenetration with mucin, resulting consequently in the augmentation of bioadhesive strength. 33 Application of 2-way ANOVA-based factorial analysis indicated that both the polymers had very significant influence on the bioadhesive properties of the compressed matrices (P < .001 in each case).
RSM Optimization Results
Mathematical Modeling
Mathematical relationships generated using MLRA for the studied response variables are expressed as Equations 2 through 5. 
All the polynomial equations were found to be statistically significant (P < .01), as determined using ANOVA, as per the provision of Design Expert software.
The polynomial equations comprise the coefficients for intercept, first-order main effects, interaction terms, and higherorder effects. The sign and magnitude of the main effects signify the relative influence of each factor on the response. The values obtained for main effects of each factor in Equations 2 and 3 reveal that Na CMC, individually, has rather more pronounced effect on the values of t 50% and rel 18h , respectively. On the other hand, the main effect coefficients in Equations 4 and 5 show that CP has a more influential role on the response variables, n and f. At a given set of factor levels, however, these higher-order polynomials yield results as the net effect of all the coefficient terms contained in the polynomial.
Response Surface Analysis
Figures 3A to 6A portray the 3-dimensional response surface plots, while Figures 3B to 6B are the corresponding contour plots for the studied response properties viz t 50% , rel 18h , n, and f. Figures 3A and B depict a nonlinear trend of t 50% in an ascending order, with an augmentation of CP levels. However with Na CMC, this inclining trend is observed until intermediate level, followed by an asymptotic 
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plateau at higher levels. This may be explained on the basis of mathematical models generated for the response variable, t 50% (Equation 2). It can be deduced from the model that at higher levels of Na CMC, the negative influence of higher-order terms (eg, X 2 2 , X 1 X 2 , X 1 2 X 2 ) tend to outweigh the positive linear contribution of the polymer (X 2 ) alone.
Figures 4A and B also exhibit that rel 18h vary in a nonlinear manner, but in a descending pattern with an increase in the amount of each polymer. Except at high level of CP, this declining trend was observed until intermediate levels of Na CMC, after which a near plateau was discernible (ie, the drug release values did not decrease appreciably). The contour plot ( Figure 4B) shows that Na CMC has a comparatively greater influence on the response variable than CP.
Figures 5A and B show a "region of maximum" for n, lying between the intermediate to high levels of both the polymers. Herein, the values of n tend to indicate nearly zeroorder release kinetics within the experimental domain.
In contrast to the results of drug release parameters, response surface and contour plot for f ( Figures 6A and B) reveal that f varies in somewhat linear fashion with increase in the amount of each polymer. However, the effect of CP seems to be more pronounced as compared with that of Na CMC.
The optimum formulation was selected based on the criteria of attaining complete and controlled drug release with highest possible bioadhesive strength. Upon "trading off " various response variables, the following maximizing criteria were adopted: t 50% > 8.0 hours; rel 18h > 85%; n > 0.80; f > 25 g. Upon comprehensive evaluation of feasibility search and subsequently exhaustive grid searches, the formulation composition with polymer levels of CP, 78.5 mg, and Na CMC, 195 mg, fulfilled maximum requisites of an optimum formulation because of better regulation of release rate and higher bioadhesive strength. The formulation showed t 50% as 8.58 hours, rel 18h as 91.59%, n as 0.8178 and f as 27.79 g. The said formulation, however, released the drug completely (ie, 99.78% drug in 24 hours).
Validation of RSM Results
For all of the 8 checkpoint formulations, the results of the physical evaluation and tablet assay were found to be within limits. Table 4 lists the compositions of the checkpoints, their predicted and experimental values of all the response variables, and the percentage error in prognosis. Figure 7 shows linear correlation plots between the observed and predicted response variables, and the residual plots showing the scatter of the residuals versus observed values.
Upon comparison of the observed responses with that of the anticipated responses, the prediction error varied between −1.803% and 2.82% (mean ± SD as −0.0072 ± 1.087). The linear correlation plots drawn between the predicted and observed responses demonstrated high values of r 2 (ranging between 0.9617 and 0.9983), indicating excellent goodness of fit (P < .001). Relatively less magnitudes of r 2 observed with f (0.9617) and t 50% (0.9676) could be attributed to the biological variation of the model membrane (porcine gastric mucosa) and indirect estimation of t 50% values through interpolation techniques, respectively. Upon validation, the optimum formulation exhibited percentage error for various response variables, varying between −0.849% and 0.109%. Thus, the low magnitudes of error as well as the significant values of r 2 in the current study indicate a high prognostic ability of RSM. 
